| Filed On | Filing |
|---|---|
| 08 Oct 2026 |
Form 3: Asp Isotopes Inc., 10% owner and 1 other · ENDRA Life Sciences Inc
Holds 66,846 shares of Common Stock |
| 28 Nov 2025 |
Form 3: Hunter Ralph L. Jr, Director
Holds 0 shares of Common Stock, par value $0.01 per share |
| 28 Nov 2025 |
Form 3: Ainscow Donald George, EVP, Gen Counsel, Secretary
Holds 100,000 shares of Common Stock, par value $0.01 per share |
| 16 Oct 2024 |
Form 3: Ak Jensen Investment Management Ltd, 10% owner
Holds 6,716,874 shares of Common Stock, par value $0.01 per share |
| 01 Jul 2024 |
Form 3: Kiessling Heather, Chief Financial Officer
Holds 12,500 shares of Common Stock, par value $0.01 per share |
| 26 Feb 2024 |
Form 3: Ryan Robert John Andrew, Director
Holds 468,458 shares of Common Stock, par value $0.01 per share |
| 26 Feb 2024 |
Form 3: Gorley Michael, Director
No securities owned |
| 19 Oct 2023 |
Form 3: Ak Jensen Investment Management Ltd, 10% owner
Holds 6,516,874 shares of Common Stock, par value $0.01 per share |
| 14 Nov 2022 |
Form 3: Wider Todd, Director
Holds 200,000 shares of Common Stock |
| 14 Nov 2022 |
Form 3: Vasnetsov Sergey, Director
Holds 600,000 shares of Common Stock |
| 14 Nov 2022 |
Form 3: Strydom Hendrik, Director
Holds 3,597,423 shares of Common Stock |
| 14 Nov 2022 |
Form 3: Ronander Einar, 10% owner
Holds 3,597,424 shares of Common Stock |
| 14 Nov 2022 |
Form 3: Moore Duncan, Director
Holds 200,000 shares of Common Stock |
| 14 Nov 2022 |
Form 3: Mann Paul Elliot, Director
Holds 3,050,000 shares of Common Stock |
| 14 Nov 2022 |
Form 3: Donfeld Joshua Jay, Director
Holds 800,000 shares of Common Stock |
| 14 Nov 2022 |
Form 3: Ainscow Robert, Chief Financial Officer
Holds 250,000 shares of Common Stock |
Loading...